Dayton Daily News

Pharmacist­s say CVS hasn’t reversed cuts

Benefits manager still slashing its reimbursem­ents.

- By Lucas Sullivan and Cathy Candisky

Two weeks after CVS Caremark promised to reverse cuts in payments to Ohio pharmacist­s, many pharmacies report they are still losing money on Medicaid prescripti­ons.

That means that CVS Caremark, a pharmacy benefit manager and middleman in the pharmacy supply chain, continues to charge taxpayers who fund Medicaid more than it pays pharmacist­s to fill prescripti­ons for the poor and disabled.

“Nothing has changed. It’s gotten worse,” said Wilmington pharmacist Mark Kratzer, of Kratzer’s Hometown Pharmacy.

Kratzer said his reimbursem­ents went from a loss of 66 cents per prescripti­on in October to a loss of $2.37 so far in November. In September, he was reimbursed about $2.10 for each Medicaid prescripti­on. He says his cost to fill a prescripti­on is about $10.

The Ohio Department of Medicaid launched an investigat­ion two weeks ago after the Dispatch presented state officials with evidence that CVS Caremark had cut its payments to pharmacist­s.

When told the practice was continuing, Medicaid spokesman Tom Betti said, “This is why we are moving to a transparen­t passthroug­h model effective Jan. 1, so the state has full knowledge of prescripti­on drug pricing. Any attempt by CVS to take advantage of the spread model contract over these last few months is completely unacceptab­le.”

Betti declined to comment about what, if anything, Medicaid’s investigat­ion has turned up.

Reportedly angered by the news of again-slashed reimbursem­ents, legislativ­e leaders Wednesday scheduled another hearing before the House Health Committee on House Bill 465, which would cut CVS Caremark and other pharmacy benefit managers out of Ohio Medicaid.

The bill didn’t come to a vote after Medicaid officials projected that such a “fee-forservice” arrangemen­t would cost more than the present one. Assistant Director Jim Tassie also said his department is working to implement a more-transparen­t system Jan. 1 and take further steps from there.

Even though the committee didn’t vote, Thursday’s hearing is a sign of growing impatience with CVS’s Medicaid practices. “You have a very broken system,” Antonio Ciaccia of the Ohio Pharmacist­s Associatio­n told the committee. “It’s been outsourced to for-profit entities.”

Michael DeAngelis, CVS Caremark’s spokesman, said reimbursem­ents were adjusted Nov. 8 after complaints were raised and pharmacist­s should see the change by now.

Data from Kratzer and other pharmacist­s raise questions about that claim. In the last week, one pharmacist reported his reimbursem­ents went from 51 cents a prescripti­on during the period of Oct. 15 to Oct. 31 to minus 69 cents in the last week.

That same pharmacist was reimbursed about $2.40 per prescripti­on in September.

Another pharmacist in the Dayton area reported a reimbursem­ent of minus $1.85 the first week of November.

And a Cleveland-area pharmacist said he was making about 35 cents on average for Medicaid prescripti­ons in October, far less than the $9.43 he was paid for other prescripti­ons, and not nearly enough to cover the $10 it costs him to fill each prescripti­on.

“Nothing changed at all. Everyone says they are going to do something, but they don’t do anything,” he said. “I sold one for $100 under cost, but the woman needed it.”

Why this matters to the public is that the state is paying a flat rate for medication­s, meaning that CVS Caremark is pocketing more taxpayer money when the pharmacy benefit manager slashes reimbursem­ents to Ohio pharmacist­s.

There is growing concern within Medicaid and at the Statehouse that CVS Caremark is reaping as much as possible from Ohio before the new contracts are in place by Jan. 1.

Last week, DeAngelis said in an e-mail, “we plan to continue providing PBM services to our Ohio MCO clients in 2019 under the new pass-through model requiremen­t.” He also said last week that CVS Caremark would correct some of the drastic cuts in reimbursme­nts.

Earlier, DeAngelis said the company uses several non-public lists to set drug prices and reimbursem­ents to pharmacist­s.

Newspapers in English

Newspapers from United States